In the present study, we found 3 out of 12 patients (25%) with BRCA1/2 mutations had bilateral breast cancer (one with metachronous bilateral breast cancer and two with synchronous bilateral breast cancer). This evidence concerns the gene BRCA1 and breast cancer.